• LANREOTIDE CHEMBL1201185 FDA ApprovedAntineoplastic

    Alternate Names:

    Somatuline Autogel
    Lanreotide
    Somatuline LA
    C1523
    BIM-23014
    Somatuline Depot
    Somatuline
    108736-35-2
    DB06791
    135652022
    2031
    123369-01-7
    10-(4-AMINOBUTYL)-19-[[2-AMINO-3-(2-NAPHTHYL)PROPANOYL]AMINO]-N-(1-CARBAMOYL-2-HYDROXY-PROPYL)-16-[(4-HYDROXYPHENYL)METHYL]-13-(1H-INDOL-3-YLMETHYL)-7-ISOPROPYL-6,9,12,15,18-PENTAOXO-1,2-DITHIA-5,8,11,14,17-PENTAZACYCLOICOSANE-4-CARBOXAMIDE
    10-(4-AMINOBUTYL)-19-[(2-AMINO-3-NAPHTHALEN-2-YL-PROPANOYL)AMINO]-N-(1-CARBAMOYL-2-HYDROXY-PROPYL)-16-[(4-HYDROXYPHENYL)METHYL]-13-(1H-INDOL-3-YLMETHYL)-6,9,12,15,18-PENTAOXO-7-PROPAN-2-YL-1,2-DITHIA-5,8,11,14,17-PENTAZACYCLOICOSANE-4-CARBOXAMIDE
    BETA-(2-NAPHTHYL)-D-ALA-CYS-TYR-D-TRP-LYS-VAL-CYS-THR AMIDE [DISULFIDE BRIDGE: 2-7
    L000343
    33928-EP2311829A1
    33928-EP2311808A1
    33928-EP2311453A1
    33928-EP2305642A2
    33928-EP2298765A1
    33928-EP2298764A1
    33928-EP2298748A2
    33928-EP2295427A1
    33928-EP2295426A1
    33928-EP2295416A2
    33928-EP2295055A2
    33928-EP2275420A1
    33928-EP2272827A1
    127984-74-1
    LS-172394
    LS-153748
    L-THREONINAMIDE, 3-(1-NAPHTHALENYL)-D-ALANYL-L-CYSTEINYL-L-TYROSYL-D-TRYPTOPHYL-L-LYSYL-L-VALYL-L-CYSTEINYL-, CYCLIC (2-7)-DISULFIDE
    AN-33681
    118992-92-0
    NCGC00181321-01
    DAP001488
    127984-74-1 (ACETATE SALT)
    C54H69N11O10S2
    CTK8G7572
    SCHEMBL14802383
    GTPL2031
    UNII-0G3DE8943Y
    N9642_SIGMA
    SCHEMBL34091
    AC1L2FZT
    LANREOTIDE [INN:BAN]
    SOMATULIN-AUTOGEL
    SOMATULINEREG
    LANREOTIDUM
    LANREOTIDA
    IPSTYL
    L-THREONINAMIDE, 3-(2-NAPHTHALENYL)-D-ALANYL-L-CYSTEINYL-L-TYROSYL-D-TRYPTOPHYL-L-LYSYL-L-VALYL-L-CYSTEINYL-, CYCLIC (2-7)-DISULFIDE
    NAL-CYCLO(CYS-TYR-TRP-LYS-VAL-CYS)-THR-NH2
    LANREOTIDA [INN-SPANISH]
    LANREOTIDUM [INN-LATIN]
    DC 13-116
    BIM 23014
    LANREOTIDE AUTOGEL
    AUTOGEL
    SOMATULIN
    71349
    213580

    Drug Info:

    Year of Approval 2007
    Drug Class hormone replacement agents
    FDA Approval approved
    Drug Class Small molecule
    Drug Indications for treatment of acromegaly
    Drug Categories therapeutic uses
    Drug Categories systemic hormonal preparations, excl. sex hormones and insulins
    Drug Categories somatostatin and analogues
    Drug Categories somatostatin analogs
    Drug Categories proteins
    Drug Categories polycyclic compounds
    Drug Categories pituitary hormone release inhibiting hormones
    Drug Categories pituitary and hypothalamic hormones and analogues
    Drug Categories physiological effects of drugs
    Drug Categories pharmacologic actions
    Drug Categories peptides
    Drug Categories peptide hormones
    Drug Categories pancreatic hormones
    Drug Categories neuropeptides
    Drug Categories nerve tissue proteins
    Drug Categories macrocyclic compounds
    Drug Categories hypothalamic hormones
    Drug Categories hypoglycemia-associated agents
    Drug Categories hyperglycemia-associated agents
    Drug Categories hormones, hormone substitutes, and hormone antagonists
    Drug Categories hormones
    Drug Categories chemical actions and uses
    Drug Categories bradycardia-causing agents
    Drug Categories blood glucose lowering agents
    Drug Categories antineoplastic agents
    Drug Categories amino acids, peptides, and proteins
    Drug Categories acromegaly
    Drug Groups approved
    Drug Type small molecule
    (4 More Sources)